News items Vidi-subsidie voor vier Radboud onderzoekers
30 May 2017

Four researchers from Nijmegen – three from Radboudumc and one from Radboud University – are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO (The Netherlands Organisation for Scientific Research) is awarding the Vidi grant as part of the Innovational Research Incentives Scheme.

Vidi is aimed at excellent researchers who have been producing successful research for a number of years since obtaining their PhD. These academics are among the best 10 to 20% in their field. A Vidi will allow them to conduct research for a period of five years. In this way, NWO stimulates curiosity-driven and innovative research.

Three researchers at the Radboudumc will receive a Vidi grant: Dr Ir Sita Vermeulen, Dr Vivian Weerdesteyn and Dr Christian Gilissen. In addition, one researcher from the Radboud University has also been awarded a Vidi grant: Dr Hanneke den Ouden. Information about the scientists and their research is given below.

Researchers at the Radboudumc

Matching therapy and bladder cancer patient Sita Vermeulen Radboudumc – Health Evidence
A good therapy choice in non-muscle invasive bladder cancer requires a test that can predict who will and who will not respond to immunotherapy. The researchers measure changes in the genes of the patient and the bladder tumor to facilitate the development of such a test.

Roads to Recovery                                                 
Dr. Vivian Weerdesteyn, Radboudumc – Kinesiology / Rehabilitation medicine                                              
It is yet unknown how various pathways in the brain interact in recovering balance and gait abilities after stroke. The researchers aim to provide insight into this matter. In addition, they will study whether a new training program may enhance balance and gait control, and thereby functioning in daily life.

Integrating Metabolomics and Genomics for understanding human Disease
Dr. Christian Gilissen, Radboudumc – Human Genetics
The identification of disease-causing errors in the DNA is difficult and provides us with limited insights into the workings of the disease. Through bioinformatics methods and data integration of metabolite and DNA data I will improve the identification of genetic causes of disease and find novel leads for therapies.

Researcher at the Radboud University
Getting things done: finding the balance between deciding fast, and deciding well
Dr. Hanneke den Ouden, Radboud University - Donders Institute for Brain, Cognition and Behaviour
"Don't rush decisions!" Good advice, but too much deliberation can lead to missed opportunities. Hanneke Den Ouden will investigate how our brains help us switch between impulsive and thoughtful decision-making strategies. Furthermore, she will research how getting stuck in one particular strategy may be related to negative consequences such as addiction and burn-out.

Read the press release by NWO here
  • Want to know more about these subjects? Click on the buttons below for more news.

    ResearchNieuws home

Related news items

Frank Walboomers 25-years work anniversary at Radboudumc

17 September 2020

Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.

read more

Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes

17 September 2020

Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.

read more

Annette Schenck appointed professor of Translational Genetics

17 September 2020

Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.

read more

Transfer of new anti-hepatitis C drugs across the human placenta

9 September 2020

In a recent publication in American Journal of Obstetrics and Gynecology, researchers from the Departments of Pharmacology and Toxicology, Pharmacy, Obstetrics and Gynecology, Gastroenterology and Hepatology, investigated the placental passage of two such drugs for the first time.

read more

Nanda Rommelse appointed endowed professor of Neurodevelopmental disorders

8 September 2020

Nanda Rommelse has been appointed professor of Neurodevelopmental disorders with effect from 1 September. The chair will function as a bridge between the Psychiatry Department of the Radboudumc with Karakter Child and Adolescent Psychiatry.

read more

Does the COVID-19 cytokine storm exist? Research may have an impact on the chances of success of a specific treatment

4 September 2020

Following the measurement of several important cytokines in patients with COVID-19 and various other severe diseases, researchers at Radboud university medical center now show that COVID-19 is not characterized by a cytokine storm.

read more